Literature DB >> 22854891

ADA/EASD position statement of the treatment of type 2 diabetes: Reply to Rodbard HW and Jellinger PS [letter], Scheen AJ [letter] and Ceriello A, Gallo M, Gentile S et al [letter].

D R Matthews1,2,3, S E Inzucchi4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22854891     DOI： 10.1007/s00125-012-2669-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  5 in total

1.  Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal:  Diabetologia       Date:  2012-04-20       Impact factor: 10.122

2.  Controversy about the relative efficacy of dipeptidyl peptidase IV inhibitors.

Authors:  A J Scheen
Journal:  Diabetologia       Date:  2012-07-07       Impact factor: 10.122

3.  Efficacy and safety comparison between the DPP-4 inhibitor vildagliptin and the sulfonylurea gliclazide after two years of monotherapy in drug-naïve patients with type 2 diabetes.

Authors:  J E Foley; S Sreenan
Journal:  Horm Metab Res       Date:  2009-08-24       Impact factor: 2.936

4.  A critique of the 2012 ADA/EASD position statement.

Authors:  H W Rodbard; P S Jellinger
Journal:  Diabetologia       Date:  2012-07-18       Impact factor: 10.122

5.  Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.

Authors:  Thomas Karagiannis; Paschalis Paschos; Konstantinos Paletas; David R Matthews; Apostolos Tsapas
Journal:  BMJ       Date:  2012-03-12
  5 in total
  1 in total

Review 1.  Indirect comparison of lixisenatide versus neutral protamine Hagedorn insulin as add-on to metformin and sulphonylurea in patients with type 2 diabetes mellitus.

Authors:  Marie Fournier; Maeva Germe; Karlheinz Theobald; Gerhard H Scholz; Walter Lehmacher
Journal:  Ger Med Sci       Date:  2014-10-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.